Platelet CD154 Potentiates Interferon-α Secretion by Plasmacytoid Dendritic Cells in Systemic Lupus Erythematosus
P. Duffau(Centre National de la Recherche Scientifique), Patrick Blanco(Centre National de la Recherche Scientifique), Frédéric Batteux(Délégation Paris 5), Bernard Weil(Délégation Paris 5), Cécile Bordes(Centre National de la Recherche Scientifique), Carole Nicco(Centre National de la Recherche Scientifique), Isabelle Douchet(Centre National de la Recherche Scientifique), Christophe Richez(Boston University), Estibaliz Lazaro(Centre National de la Recherche Scientifique), Jean‐Luc Pellegrin(Centre National de la Recherche Scientifique), Claire Goulvestre(Délégation Paris 5), Julien Sénéschal(Université de Bordeaux), Jean‐François Viallard(Centre Hospitalier Universitaire de Bordeaux), Jean‐François Moreau(Centre National de la Recherche Scientifique)
Cited by 219
Related Papers
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
|New England Journal of Medicine|2019|1.3k
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*
|British Journal of Dermatology|2021|414
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|261